![]() Menlo Therapeutics Menlo Therapeutics is a clinical stage pharmaceutical company dedicated to the development of serlopitant. | ![]() ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | ![]() Chondrial Therapeutics Chondrial Therapeutics is engaged in discovering and developing orphan drugs for mitochondrial diseases. | ||
Founding Date | Founding Date 2018 | Founding Date 2011 | Founding Date 2003 | Founding Date 2013 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations Redwood City, US HQ Ness Ziona, IL Bridgewater Township, US | Locations Athens, US HQ Athens, US | Locations Bala Cynwyd, US HQ Indianapolis, US |
Employees | Employees 2318% decrease | Employees 26 | Employees 274% increase | Employees 736% increase |
Funding | ||||
Latest funding round | Latest funding round $ 50m (almost 6 years ago) | Latest funding round N/A | Latest funding round $ 4.5m (over 6 years ago) | Latest funding round $ 22.6m (over 9 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 50m | Total funding raised $ 26.9m | Total funding raised $ 23.6m |

Menlo Therapeutics is a clinical stage pharmaceutical company dedicated to the development of serlopitant.
View company
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company
Chondrial Therapeutics is engaged in discovering and developing orphan drugs for mitochondrial diseases.
View company